Infectious Diseases: Prevention, Diagnosis, and Treatment Under Antimicrobial Resistance Global Urgency
A special issue of Biomedicines (ISSN 2227-9059). This special issue belongs to the section "Microbiology in Human Health and Disease".
Deadline for manuscript submissions: 31 May 2025 | Viewed by 624
Special Issue Editor
2. LEPABE—Laboratory for Process Engineering, Environment, Biotechnology and Energy, University of Porto, 4200-465 Porto, Portugal
Interests: biofilms; fungal and bacterial infections; resistance to antimicrobials; microfluidics; pathogens detection; alternative therapies; surface functionalization of biomaterials
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
The rise of antimicrobial resistance (AMR) presents an urgent global challenge in the fight against infectious diseases caused by bacteria, fungi, and viruses. Once-treatable infections are now becoming harder to manage as pathogens have evolved to resist common antimicrobial agents. This growing threat calls for a holistic approach for prevention, diagnosis, and treatment. Prevention is the frontline defense in slowing the spread of resistant infections. Vaccination programs, improved hygiene, and strict infection control measures are essential in reducing transmission, while public health campaigns encourage responsible antibiotic use. In both healthcare and agriculture, limiting unnecessary antibiotic exposure is critical to slowing resistance. Rapid, precise diagnostic tools are needed to accurately identify infections, distinguishing between bacterial, fungal, or viral origins. This allows for more targeted treatments, reducing the misuse of broad-spectrum antibiotics, which drive resistance.
As AMR spreads, the available treatments become increasingly complex. The shrinking effectiveness of existing antimicrobials emphasizes the need for new drugs and alternative therapies. Research into combination therapies, natural compounds, phage therapy, and innovative immunotherapies holds promise for treating resistant infections. In the meantime, antibiotic stewardship programs help optimize the use of current treatments, ensuring that they remain effective for as long as possible.
The AMR crisis demands global cooperation across sectors, from healthcare to agriculture, to safeguard the future of infectious disease management. We can only prevent a post-antibiotic era from becoming a reality through a coordinated, multidisciplinary effort. This Special Issue aims to focus on all these key points.
Dr. Célia F. Rodrigues
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Biomedicines is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- AMR
- infectious diseases
- bacteria
- fungi
- alternative treatment
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.
